Delivery Order SPE2DR25D1104-SPE2DR26FK621
- Not listed
- The Defense Logistics Agency awarded a $5,657.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary operations supporting federal medical...
- The Defense Logistics Agency awarded a $3,184.17 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $3,534.20 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on November 17, 2025, with an ultimate completion date of November 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $2,325.92, with completion targeted for October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,381.44. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors with a ceiling value of $2,907.40. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors, with a ceiling value of $1,105.64 and an ultimate completion date of November 26, 2025. The contract was competitively awarded without set-aside restrictions and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,374.50 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK621Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,341.89 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injectors on December 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 11, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally. The Trulicity procurement exemplifies the company's role in providing critical diabetes medications and other specialized therapeutics to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/9/25 |